Nantong Jinghua Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.032x

Nantong Jinghua Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Nantong Jinghua Pharmaceutical Co Ltd (002349) has a cash flow conversion efficiency ratio of 0.032x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥97.93 Million ≈ $14.33 Million USD) by net assets (CN¥3.09 Billion ≈ $452.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Nantong Jinghua Pharmaceutical Co Ltd (2006–2025)

Cash flow conversion efficiency of Nantong Jinghua Pharmaceutical Co Ltd from 2006 to 2025. This chart illustrates how Nantong Jinghua Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 002349 stock price for real-time trading data and today's change.

Nantong Jinghua Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Nantong Jinghua Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Nantong Jinghua Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nantong Jinghua Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see 002349 market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Zhejiang Whwh SHG:600576	0.061x
R&S GROUP HOLDING AG SW:RSGN	2.091x
Prosiebensat 1 Media AG XETRA:PSM	0.137x
Shanghai Prisemi Electronics Co Ltd SHG:688230	0.012x
Raymond Limited NSE:RAYMOND	-0.011x
ODP Corp NASDAQ:ODP	0.109x
Nuveen Select Tax-Free Income Portfolio NYSE:NXP	-0.002x
Phoenix Education Partners, Inc. NYSE:PXED	0.113x

Annual Cash Flow Conversion Efficiency for Nantong Jinghua Pharmaceutical Co Ltd (2006–2025)

The table below shows the annual cash flow conversion efficiency of Nantong Jinghua Pharmaceutical Co Ltd from 2006 to 2025. Review 002349 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.15 Billion ≈ $460.83 Million	CN¥340.87 Million ≈ $49.88 Million	0.108x	+2.91%
2024-12-31	CN¥2.96 Billion ≈ $432.72 Million	CN¥311.02 Million ≈ $45.51 Million	0.105x	+1.25%
2023-12-31	CN¥2.80 Billion ≈ $410.35 Million	CN¥291.31 Million ≈ $42.63 Million	0.104x	-23.95%
2022-12-31	CN¥2.62 Billion ≈ $383.94 Million	CN¥358.39 Million ≈ $52.44 Million	0.137x	+14.86%
2021-12-31	CN¥2.57 Billion ≈ $376.01 Million	CN¥305.57 Million ≈ $44.71 Million	0.119x	-9.90%
2020-12-31	CN¥2.49 Billion ≈ $363.89 Million	CN¥328.22 Million ≈ $48.03 Million	0.132x	-0.67%
2019-12-31	CN¥2.15 Billion ≈ $314.28 Million	CN¥285.38 Million ≈ $41.76 Million	0.133x	+329.14%
2018-12-31	CN¥2.69 Billion ≈ $394.28 Million	CN¥83.43 Million ≈ $12.21 Million	0.031x	+7.96%
2017-12-31	CN¥2.65 Billion ≈ $387.36 Million	CN¥75.92 Million ≈ $11.11 Million	0.029x	-80.79%
2016-12-31	CN¥2.30 Billion ≈ $336.95 Million	CN¥343.80 Million ≈ $50.31 Million	0.149x	+538.78%
2015-12-31	CN¥2.23 Billion ≈ $326.88 Million	CN¥-76.01 Million ≈ $-11.12 Million	-0.034x	-214.26%
2014-12-31	CN¥1.53 Billion ≈ $224.56 Million	CN¥45.70 Million ≈ $6.69 Million	0.030x	+140.21%
2013-12-31	CN¥741.83 Million ≈ $108.55 Million	CN¥-54.94 Million ≈ $-8.04 Million	-0.074x	-168.54%
2012-12-31	CN¥714.87 Million ≈ $104.61 Million	CN¥77.25 Million ≈ $11.30 Million	0.108x	+65.90%
2011-12-31	CN¥636.30 Million ≈ $93.11 Million	CN¥41.45 Million ≈ $6.06 Million	0.065x	-13.63%
2010-12-31	CN¥544.45 Million ≈ $79.67 Million	CN¥41.06 Million ≈ $6.01 Million	0.075x	-82.10%
2009-12-31	CN¥137.11 Million ≈ $20.06 Million	CN¥57.76 Million ≈ $8.45 Million	0.421x	+191.81%
2008-12-31	CN¥118.66 Million ≈ $17.36 Million	CN¥17.13 Million ≈ $2.51 Million	0.144x	-60.84%
2007-12-31	CN¥91.86 Million ≈ $13.44 Million	CN¥33.86 Million ≈ $4.96 Million	0.369x	+16.34%
2006-12-31	CN¥70.00 Million ≈ $10.24 Million	CN¥22.18 Million ≈ $3.25 Million	0.317x	--

About Nantong Jinghua Pharmaceutical Co Ltd

SHE:002349 China Drug Manufacturers - Specialty & Generic

Market Cap

$844.04 Million

CN¥5.77 Billion CNY

Market Cap Rank

#9285 Global

#2250 in China

Share Price

CN¥6.94

Change (1 day)

-0.57%

52-Week Range

CN¥6.08 - CN¥9.26

All Time High

CN¥25.53